{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:41:10Z","timestamp":1783716070856,"version":"3.55.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202152"],"award-info":[{"award-number":["7202152"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670329"],"award-info":[{"award-number":["81670329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974183"],"award-info":[{"award-number":["81974183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0901502"],"award-info":[{"award-number":["2016YFC0901502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Rationale:<\/jats:bold> Patients suffering from coronary artery disease (CAD) complicated with nonalcoholic fatty liver disease (NAFLD) present worse cardiovascular outcomes than CAD patients without NAFLD. The progression of CAD is recently reported to be associated with gut microbiota and microbe-derived metabolites. However, it remains unclear how the complication of NAFLD will affect gut microbiota and microbe-derived metabolites in CAD patients, and whether or not this interplay is related to the worse cardiovascular outcomes in CAD-NAFLD patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We performed 16S rRNA sequencing and serum metabolomic analysis in 27 CAD patients with NAFLD, 81 CAD patients without NAFLD, and 24 matched healthy volunteers. Predicted functional profiling was achieved using PICRUSt2. The occurrence of cardiovascular events was assessed by a follow-up study. The association of alterations in the gut microbiome and metabolome with adverse cardiovascular events and clinical indicators was revealed by Spearman correlation analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> We discovered that the complication of NAFLD was associated with worse clinical outcomes in CAD patients and critical serum metabolome shifts. We identified 25 metabolite modules that were correlated with poor clinical outcome in CAD-NAFLD patients compared with non-NAFLD patients, represented by increased cardiac-toxic metabolites including prochloraz, brofaromine, aristolochic acid, triethanolamine, and reduced potentially beneficial metabolites including estradiol, chitotriose, palmitelaidic acid, and moxisylyte. In addition, the gut microbiome of individuals with CAD-NAFLD was changed and characterized by increased abundances of <jats:italic>Oscillibacter ruminantium<\/jats:italic> and <jats:italic>Dialister invisus<\/jats:italic>, and decreased abundances of <jats:italic>Fusicatenibacter saccharivorans, Bacteroides ovatus<\/jats:italic> and <jats:italic>Prevotella copri<\/jats:italic>. PICRUSt2 further confirmed an increase of potential pathogenic bacteria in CAD-NAFLD. Moreover, we found that variations of gut microbiota were critically correlated with changed circulating metabolites and clinical outcomes, which revealed that aberrant gut microbiota in CAD-NAFLD patients may sculpt a detrimental metabolome which results in adverse cardiovascular outcomes.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our findings suggest that CAD patients complicated with NAFLD result in worse clinical outcomes possibly by modulating the features of the gut microbiota and circulating metabolites. We introduce \u201cliver-gut microbiota-heart axis\u201d as a possible mechanism underlying this interrelationship. Our study provides new insights on the contribution of gut microbiota heterogeneity to CAD-NAFLD progression and suggests novel strategies for disease therapy.<\/jats:p>","DOI":"10.3389\/fcvm.2021.805812","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T06:48:07Z","timestamp":1641192487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes"],"prefix":"10.3389","volume":"8","author":[{"given":"Xiaomin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueshen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"Nonalcoholic fatty liver disease: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2020","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1038\/d41586-017-06927-0","article-title":"Fatty liver disease","volume":"551","author":"Brody","year":"2017","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323202","article-title":"From the origin of NASH to the future of metabolic fatty liver disease","author":"Geier","year":"2021","journal-title":"Gut."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","author":"Mantovani","year":"2020","journal-title":"Gut."},{"key":"B6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.14309\/ajg.0000000000000153","article-title":"Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver disease","volume":"114","author":"Petta","year":"2019","journal-title":"Am J Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.2019.10696","article-title":"Testing for nonalcoholic fatty liver disease","volume":"322","author":"Juo","year":"2019","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3748\/wjg.v26.i19.2416","article-title":"Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: the gut and obesity Asia initiative","volume":"26","author":"Pitisuttithum","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjcard.2019.05.028","article-title":"Nonalcoholic fatty liver disease is associated with arterial distensibility and carotid intima-media thickness: (from the multi-ethnic study of atherosclerosis)","volume":"124","author":"Oni","year":"2019","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.clinre.2017.01.005","article-title":"Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation","volume":"41","author":"Cetindagli","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1210\/jc.2013-4133","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance","volume":"99","author":"Kim","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3892\/etm.2018.7043","article-title":"Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD","volume":"17","author":"Wang","year":"2019","journal-title":"Exp Ther Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hep.28306","article-title":"Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram","volume":"64","author":"Targher","year":"2016","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1038\/d41586-017-06924-3","article-title":"Gut-liver axis: menace in the microbiota","volume":"551","author":"Scott","year":"2017","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12864-019-6251-7","article-title":"Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Genomics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome."},{"key":"B22","doi-asserted-by":"publisher","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.7150\/thno.55946","article-title":"Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/bioinformatics\/bts198","article-title":"Accurate extension of multiple sequence alignments using a phylogeny-aware graph algorithm","volume":"28","author":"Loytynoja","year":"2012","journal-title":"Bioinformatics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/heart.83.4.371","article-title":"Troponin T or troponin I as cardiac markers in ischaemic heart disease","volume":"83","author":"Maynard","year":"2000","journal-title":"Heart."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group fragmin during instability in coronary artery disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e109761","DOI":"10.1371\/journal.pone.0109761","article-title":"Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients","volume":"9","author":"Serra e Silva Filho","year":"2014","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.104.511998","article-title":"Periodontal disease and coronary heart disease: a reappraisal of the exposure","volume":"112","author":"Beck","year":"2005","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fcimb.2020.00373","article-title":"Alterations of gut microbiome in tibetan patients with coronary heart disease","volume":"10","author":"Liu","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2021.01.009","article-title":"Bacteroides ovatus promotes IL-22 production and reduces trinitrobenzene sulfonic acid-driven colonic inflammation","author":"Ihekweazu","year":"2021","journal-title":"Am J Pathol."},{"key":"B34","first-page":"3445","article-title":"Changes and roles of intestinal fungal microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease","volume":"12","author":"Xu","year":"2020","journal-title":"Am J Transl Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jacc.2019.11.060","article-title":"Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk","volume":"75","author":"Heianza","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"22525","DOI":"10.1038\/srep22525","article-title":"Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease","volume":"6","author":"Feng","year":"2016","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1665-2681(19)30760-4","article-title":"Fatty liver and abdominal fat relationships with high C-reactive protein in adults without coronary heart disease","volume":"14","author":"Cardoso-Salda\u00f1a","year":"2015","journal-title":"Ann Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2000375","DOI":"10.1002\/mnfr.202000375","article-title":"The gut microbiota and its metabolites, novel targets for treating and preventing non-alcoholic fatty liver disease","volume":"64","author":"Ni","year":"2020","journal-title":"Mol Nutr Food Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and Fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"124240","DOI":"10.1016\/j.jhazmat.2020.124240","article-title":"Health risks of chlorothalonil, carbendazim, prochloraz, their binary and ternary mixtures on embryonic and larval zebrafish based on metabolomics analysis","volume":"404","author":"Yang","year":"2021","journal-title":"J Hazard Mater."},{"key":"B43","doi-asserted-by":"publisher","first-page":"124639","DOI":"10.1016\/j.jhazmat.2020.124639","article-title":"Effects of chlorothalonil, prochloraz and the combination on intestinal barrier function and glucolipid metabolism in the liver of mice","volume":"410","author":"Wang","year":"2021","journal-title":"J Hazard Mater."},{"key":"B44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11010-017-3018-9","article-title":"Effect of empagliflozin on cardiac biomarkers in a zebrafish model of heart failure: clues to the EMPA-REG OUTCOME trial?","volume":"433","author":"Shi","year":"2017","journal-title":"Mol Cell Biochem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","article-title":"Bacteroides vulgatus and bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation."},{"key":"B47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jcmgh.2016.06.004","article-title":"A Disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients","volume":"2","author":"Jacobs","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.3390\/nu12123611","article-title":"Role of oral and gut microbiota in dietary nitrate metabolism and its impact on sports performance","volume":"12","author":"Gonzalez-Soltero","year":"2020","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/antiox9070596","article-title":"Oral administration of sodium nitrate to metabolic syndrome patients attenuates mild inflammatory and oxidative responses to acute exercise","volume":"9","author":"Capo","year":"2020","journal-title":"Antioxidants"},{"key":"B51","doi-asserted-by":"publisher","first-page":"124759","DOI":"10.1016\/j.chemosphere.2019.124759","article-title":"Effects of ammonia stress on the hemocytes of the pacific white shrimp litopenaeus vannamei","volume":"239","author":"Liu","year":"2020","journal-title":"Chemosphere."},{"key":"B52","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08927014.2018.1468887","article-title":"Microbiota in a cooling-lubrication circuit and an option for controlling triethanolamine biodegradation","volume":"34","author":"Klammsteiner","year":"2018","journal-title":"Biofouling."},{"key":"B53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/cod.13201","article-title":"Contact allergy to 2-amino-2-methyl-1-propanol in a metalworking fluid","volume":"80","author":"Geier","year":"2019","journal-title":"Contact Dermatitis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"596376","DOI":"10.3389\/fimmu.2021.596376","article-title":"2-Methoxyestradiol protects against lung ischemia\/reperfusion injury by upregulating annexin A1 protein expression","volume":"12","author":"Liao","year":"2021","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"108829","DOI":"10.1016\/j.steroids.2021.108829","article-title":"17\u03b2-Estradiol alleviates cardiac aging induced by d-galactose by downregulating the methylation of autophagy-related genes","volume":"170","author":"Ye","year":"2021","journal-title":"Steroids."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2394704","DOI":"10.1155\/2020\/2394704","article-title":"Chitoheptaose promotes heart rehabilitation in a rat myocarditis model by improving antioxidant, anti-inflammatory, and antiapoptotic properties","volume":"2020","author":"Zhao","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejphar.2016.02.013","article-title":"A tetramethoxychalcone from chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia","volume":"774","author":"Luo","year":"2016","journal-title":"Eur J Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10787-020-00726-2","article-title":"Anti-inflammatory and anti-hyperalgesic effects of milnacipran in inflamed rats: involvement of myeloperoxidase activity, cytokines and oxidative\/nitrosative stress","volume":"28","author":"Haddadi","year":"2020","journal-title":"Inflammopharmacology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yexcr.2019.03.006","article-title":"Unique mechanistic insights into the beneficial effects of angiotensin-(1-7) on the prevention of cardiac fibrosis: a metabolomic analysis of primary cardiac fibroblasts","volume":"378","author":"Chen","year":"2019","journal-title":"Exp Cell Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2019.02.025","article-title":"Comparison of plasma levels of different species of trans fatty acids in Japanese male patients with acute coronary syndrome versus healthy men","volume":"284","author":"Koba","year":"2019","journal-title":"Atherosclerosis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"CD006687","DOI":"10.1002\/14651858.CD006687.pub3","article-title":"Oral vasodilators for primary raynaud's phenomenon","volume":"2012","author":"Stewart","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00784-019-03075-9","article-title":"Identification of microorganisms in irreversible pulpitis and primary endodontic infections with respect to clinical and radiographic findings","volume":"24","author":"Zargar","year":"2020","journal-title":"Clin Oral Investig."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e00457","DOI":"10.1128\/mSystems.00457-20","article-title":"Formula diet alters the ileal metagenome and transcriptome at weaning and during the postweaning period in a porcine model","volume":"5","author":"Elolimy","year":"2020","journal-title":"mSystems"},{"key":"B64","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/genes10100748","article-title":"Comparative analysis of fecal microbiota composition between rheumatoid arthritis and osteoarthritis patients","volume":"10","author":"Lee","year":"2019","journal-title":"Genes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/apt.16200","article-title":"Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis","volume":"53","author":"Kim","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1111\/bph.15226","article-title":"Protective effects of \u0394 -tetrahydrocannabinol against enterotoxin-induced acute respiratory distress syndrome are mediated by modulation of microbiota","volume":"177","author":"Mohammed","year":"2020","journal-title":"Br J Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0227147","DOI":"10.1371\/journal.pone.0227147","article-title":"Coronary artery disease is associated with an altered gut microbiome composition","volume":"15","author":"Toya","year":"2020","journal-title":"PLoS One."},{"key":"B68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3760\/cma.j.issn.0253-3766.2019.08.011","article-title":"The 8th edition of the American joint committee on cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients","volume":"41","author":"Sun","year":"2019","journal-title":"Zhonghua zhong liu za zhi."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1099\/ijs.0.045823-0","article-title":"Fusicatenibacter saccharivorans gen. nov, sp nov, isolated from human faeces","volume":"63","author":"Takada","year":"2013","journal-title":"Int J Syst Evol Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrendo.2017.85","article-title":"Metabolism: New insights into the BAT-liver-gut axis","volume":"13","author":"Morris","year":"2017","journal-title":"Nat Rev Endocrinol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.29327","article-title":"The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat","volume":"67","author":"Yip","year":"2018","journal-title":"Hepatology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.healun.2020.04.003","article-title":"The heart-gut microbiome axis in advanced heart failure","volume":"39","author":"Madan","year":"2020","journal-title":"J Heart Lung Transplant."},{"key":"B73","doi-asserted-by":"publisher","first-page":"153322","DOI":"10.1016\/j.phymed.2020.153322","article-title":"The cardiac protection of baoyuan decoction via gut-heart axis metabolic pathway","volume":"79","author":"Du","year":"2020","journal-title":"Phytomedicine."},{"key":"B74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","article-title":"The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut","volume":"585","author":"Teratani","year":"2020","journal-title":"Nature."},{"key":"B75","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"bnz009","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr Rev"},{"key":"B77","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism."},{"key":"B78","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/gutjnl-2015-310904","article-title":"Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism","volume":"66","author":"Duparc","year":"2017","journal-title":"Gut."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jacc.2016.06.044","article-title":"Comprehensive metabolomic characterization of coronary artery diseases","volume":"68","author":"Fan","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"111911","DOI":"10.1016\/j.jep.2019.111911","article-title":"Anti-inflammatory and antioxidative effects of dan-lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies","volume":"240","author":"Li","year":"2019","journal-title":"J Ethnopharmacol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T06:48:13Z","timestamp":1641192493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.805812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":80,"alternative-id":["10.3389\/fcvm.2021.805812"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.805812","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"article-number":"805812"}}